Alec Machiels
Director, Molycorp, Inc.
Companies
- Apellis Pharmaceuticals, Inc.Board member Nov 8, 2017 to now1
- CREATIVE REALITIES, INC.Board member Aug 22, 2014 to Oct 3, 20192
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Apellis Pharmaceuticals, Inc.0 shares3May 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 14, 2026Returned to company 3,544 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026Returned to company 7,961 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026Returned to company 5,744 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026Returned to company 3,062 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026U 150,000 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026U 11,950 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026U 250,000 shares of Apellis Pharmaceuticals, Inc.3
- May 14, 2026U 384,989 shares of Apellis Pharmaceuticals, Inc.3
- Jan 1, 2026Granted 7,961 shares of Apellis Pharmaceuticals, Inc.4
- Jan 1, 2025Granted 6,267 shares of Apellis Pharmaceuticals, Inc.5
- Jan 1, 2024Granted 3,341 shares of Apellis Pharmaceuticals, Inc.6
- Nov 17, 2023Sold 1,250 shares at $47.74 of Apellis Pharmaceuticals, Inc.7
- Nov 17, 2023Exercised options 1,250 shares at $2.67 of Apellis Pharmaceuticals, Inc.7
- Oct 17, 2023Sold 1,250 shares at $48.50 of Apellis Pharmaceuticals, Inc.8
- Oct 17, 2023Exercised options 1,250 shares at $2.67 of Apellis Pharmaceuticals, Inc.8
- Sep 18, 2023Sold 1,250 shares at $45.00 of Apellis Pharmaceuticals, Inc.9
- Sep 18, 2023Exercised options 1,250 shares at $2.67 of Apellis Pharmaceuticals, Inc.9
- Sep 15, 2023Sold 1,250 shares at $45.34 of Apellis Pharmaceuticals, Inc.10
- Sep 15, 2023Exercised options 1,250 shares at $2.67 of Apellis Pharmaceuticals, Inc.10
- Jul 21, 2023Exercised options 49,779 shares at $2.67 of Apellis Pharmaceuticals, Inc.11
- Jul 20, 2023Exercised options 50,000 shares at $2.67 of Apellis Pharmaceuticals, Inc.12
- Jul 17, 2023Sold 1,250 shares at $64.79 of Apellis Pharmaceuticals, Inc.13
- Jul 17, 2023Exercised options 1,250 shares at $2.67 of Apellis Pharmaceuticals, Inc.13
- Jun 20, 2023Sold 1,250 shares at $88.41 of Apellis Pharmaceuticals, Inc.14
- Jun 20, 2023Exercised options 1,250 shares at $2.67 of Apellis Pharmaceuticals, Inc.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 5, 2026
- 5SEC EDGARForm 4 filed Jan 3, 2025
- 6SEC EDGARForm 4 filed Jan 2, 2024
- 7SEC EDGARForm 4 filed Nov 20, 2023
- 8SEC EDGARForm 4 filed Oct 18, 2023
- 9SEC EDGARForm 4 filed Sep 19, 2023
- 10SEC EDGARForm 4 filed Sep 18, 2023
- 11SEC EDGARForm 4 filed Jul 24, 2023
- 12SEC EDGARForm 4 filed Jul 21, 2023
- 13SEC EDGARForm 4 filed Jul 18, 2023
- 14SEC EDGARForm 4 filed Jun 21, 2023